Huashen Technology: The listing transfer of Tibet Kangyu's 51% equity stake has been adjusted to a minimum price of 52 million yuan.

Huashen Technology Announcement: The company has publicly listed for sale 51% equity of its holding subsidiary, Tibet Kangyu Pharmaceutical Co., Ltd., with an initial listing price of 63.7806 million yuan. However, as no qualified intenders were found, it has been decided to adjust the listing price to 52 million yuan. The company will relist on the Southwest United Property Exchange. This transfer is open for public listing, and the specific transaction objects and prices are still uncertain, posing significant uncertainties and investment risks. If the transaction is successfully implemented, the company will fulfill its disclosure obligations in a timely manner based on the progress.